{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T07:11:19Z","timestamp":1694589079856},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2011,8,3]],"date-time":"2011-08-03T00:00:00Z","timestamp":1312329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s00292-011-1488-1","type":"journal-article","created":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T09:18:12Z","timestamp":1312190292000},"page":"265-270","source":"Crossref","is-referenced-by-count":2,"title":["Vorl\u00e4uferl\u00e4sionen der Ovarialkarzinome"],"prefix":"10.1007","volume":"32","author":[{"given":"A.","family":"Staebler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,8,3]]},"reference":[{"key":"1488_CR1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ygyno.2011.01.005","volume":"121","author":"Anglesio","year":"2011","unstructured":"Anglesio MS, Carey MS, Kobel M et al (2011) Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010. Gynecol Oncol 121:407\u2013415","journal-title":"Gynecol Oncol"},{"key":"1488_CR2","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/PGP.0b013e3181c713a8","volume":"29","author":"Carlson","year":"2010","unstructured":"Carlson JW, Jarboe EA, Kindelberger D et al (2010) Serous tubal intraepithelial carcinoma: diagnostic reproducibility and its implications. Int J Gynecol Pathol 29:310\u2013314","journal-title":"Int J Gynecol Pathol"},{"key":"1488_CR3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/path.2761","volume":"222","author":"Chen","year":"2010","unstructured":"Chen EY, Mehra K, Mehrad M et al (2010) Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube. J Pathol 222:110\u2013116","journal-title":"J Pathol"},{"key":"1488_CR4","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.5858\/133.11.1775","volume":"133","author":"Cho","year":"2009","unstructured":"Cho KR (2009) Ovarian cancer update: lessons from morphology, molecules, and mice. Arch Pathol Lab Med 133:1775\u20131781","journal-title":"Arch Pathol Lab Med"},{"key":"1488_CR5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.pathol.4.110807.092246","volume":"4","author":"Cho","year":"2009","unstructured":"Cho KR, Shih Ie M (2009) Ovarian cancer. Annu Rev Pathol 4:287\u2013313","journal-title":"Annu Rev Pathol"},{"key":"1488_CR6","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/PAS.0b013e318188b84c","volume":"33","author":"Cuatrecasas","year":"2009","unstructured":"Cuatrecasas M, Catasus L, Palacios J et al (2009) Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas. Am J Surg Pathol 33:556\u2013567","journal-title":"Am J Surg Pathol"},{"key":"1488_CR7","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/PAS.0b013e3181a902e1","volume":"33","author":"Geyer","year":"2009","unstructured":"Geyer JT, Lopez-Garcia MA, Sanchez-Estevez C et al (2009) Pathogenetic pathways in ovarian endometrioid adenocarcinoma: a molecular study of 29 cases. Am J Surg Pathol 33:1157\u20131163","journal-title":"Am J Surg Pathol"},{"key":"1488_CR8","doi-asserted-by":"crossref","first-page":"740968","DOI":"10.1155\/2010\/740968","volume":"2010","author":"Gilks","year":"2010","unstructured":"Gilks CB (2010) Molecular abnormalities in ovarian cancer subtypes other than high-grade serous carcinoma. J Oncol 2010:740968","journal-title":"J Oncol"},{"key":"1488_CR9","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/PAS.0b013e3181e1a3bb","volume":"34","author":"Kobel","year":"2010","unstructured":"Kobel M, Kalloger SE, Baker PM et al (2010) Diagnosis of ovarian carcinoma cell type is highly reproducible: a transcanadian study. Am J Surg Pathol 34:984\u2013993","journal-title":"Am J Surg Pathol"},{"key":"1488_CR10","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/PAS.0b013e3181dcede7","volume":"34","author":"Kuhn","year":"2010","unstructured":"Kuhn E, Meeker A, Wang TL et al (2010) Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis. Am J Surg Pathol 34:829\u2013836","journal-title":"Am J Surg Pathol"},{"key":"1488_CR11","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2353\/ajpath.2009.081000","volume":"174","author":"Kuo","year":"2009","unstructured":"Kuo KT, Mao TL, Jones S et al (2009) Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma. Am J Pathol 174:1597\u20131601","journal-title":"Am J Pathol"},{"key":"1488_CR12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","volume":"34","author":"Kurman","year":"2010","unstructured":"Kurman RJ, Shih IE M (2010) The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 34:433\u2013443","journal-title":"Am J Surg Pathol"},{"key":"1488_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.pap.0000201826.46978.e5","volume":"13","author":"Lee","year":"2006","unstructured":"Lee Y, Medeiros F, Kindelberger D et al (2006) Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer. Adv Anat Pathol 13:1\u20137","journal-title":"Adv Anat Pathol"},{"key":"1488_CR14","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.mehy.2009.11.029","volume":"74","author":"Massuger","year":"2010","unstructured":"Massuger L, Roelofsen T, Ham M et al (2010) The origin of serous ovarian cancer may be found in the uterus: a novel hypothesis. Med Hypotheses 74:859\u2013861","journal-title":"Med Hypotheses"},{"key":"1488_CR15","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","volume":"30","author":"Medeiros","year":"2006","unstructured":"Medeiros F, Muto MG, Lee Y et al (2006) The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol 30:230\u2013236","journal-title":"Am J Surg Pathol"},{"key":"1488_CR16","first-page":"625","volume":"Biosci","author":"Mehra","year":"2011","unstructured":"Mehra K, Mehrad M, Ning G et al (2011) STICS, SCOUTs and p53 signatures; a new language for pelvic serous carcinogenesis. Front Biosci (Elite Ed) 3:625\u2013634","journal-title":"Front"},{"key":"1488_CR17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAP.0b013e3181ecdee1","volume":"17","author":"Mehrad","year":"2010","unstructured":"Mehrad M, Ning G, Chen EY et al (2010) A pathologist\u2019s road map to benign, precancerous, and malignant intraepithelial proliferations in the fallopian tube. Adv Anat Pathol 17:293\u2013302","journal-title":"Adv Anat Pathol"},{"key":"1488_CR18","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1365-2559.2009.03237.x","volume":"54","author":"Piek","year":"2009","unstructured":"Piek JM, Verheijen RH, Van Diest PJ (2009) Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective. Histopathology 54:494\u2013495","journal-title":"Histopathology"},{"key":"1488_CR19","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/PAS.0b013e3181ef7b16","volume":"34","author":"Przybycin","year":"2010","unstructured":"Przybycin CG, Kurman RJ, Ronnett BM et al (2010) Are all pelvic (nonuterine) serous carcinomas of tubal origin? Am J Surg Pathol 34:1407\u20131416","journal-title":"Am J Surg Pathol"},{"key":"1488_CR20","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/modpathol.2010.60","volume":"23","author":"Sehdev","year":"2010","unstructured":"Sehdev AS, Kurman RJ, Kuhn E et al (2010) Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase. Mod Pathol 23:844\u2013855","journal-title":"Mod Pathol"},{"key":"1488_CR21","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","volume":"164","author":"Shih","year":"2004","unstructured":"Shih Ie M, Kurman RJ (2004) Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 164:1511\u20131518","journal-title":"Am J Pathol"},{"key":"1488_CR22","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/jnci\/95.6.484","volume":"95","author":"Singer","year":"2003","unstructured":"Singer G, Oldt R 3rd, Cohen Y et al (2003) Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. J Natl Cancer Inst 95:484\u2013486","journal-title":"J Natl Cancer Inst"},{"key":"1488_CR23","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/gcc.20356","volume":"45","author":"Staebler","year":"2006","unstructured":"Staebler A, Karberg B, Behm J et al (2006) Chromosomal losses of regions on 5q and lack of high-level amplifications at 8q24 are associated with favorable prognosis for ovarian serous carcinoma. Genes Chromosomes Cancer 45:905\u2013917","journal-title":"Genes Chromosomes Cancer"},{"key":"1488_CR24","doi-asserted-by":"crossref","unstructured":"Vang R, Wheeler J (2011) Diseases of the fallopian tube and the paratubal region. In: Kurman RJ, Ellenson LH, Ronnett BM (eds) Blaustein\u2019s pathology of the female genital tract. Springer, New York Dodrecht Heidelberg London, pp 529\u2013578","DOI":"10.1007\/978-1-4419-0489-8_11"},{"key":"1488_CR25","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/PAS.0b013e31819c4271","volume":"33","author":"Veras","year":"2009","unstructured":"Veras E, Mao TL, Ayhan A et al (2009) Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases. Am J Surg Pathol 33:844\u2013853","journal-title":"Am J Surg Pathol"},{"key":"1488_CR26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/PAS.0b013e3181be5d72","volume":"34","author":"Wei","year":"2010","unstructured":"Wei JJ, Wu J, Luan C et al (2010) HMGA2: a potential biomarker complement to P53 for detection of early-stage high-grade papillary serous carcinoma in fallopian tubes. Am J Surg Pathol 34:18\u201326","journal-title":"Am J Surg Pathol"},{"key":"1488_CR27","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","volume":"363","author":"Wiegand","year":"2010","unstructured":"Wiegand KC, Shah SP, Al-Agha OM et al (2010) ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 363:1532\u20131543","journal-title":"N Engl J Med"},{"key":"1488_CR28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/path.2624","volume":"220","author":"Xian","year":"2010","unstructured":"Xian W, Miron A, Roh M et al (2010) The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube. J Pathol 220:17\u201323","journal-title":"J Pathol"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-011-1488-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-011-1488-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-011-1488-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T07:25:29Z","timestamp":1638170729000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-011-1488-1"}},"subtitle":["Biologische und klinische Aspekte verschiedener Pathogenesewege"],"short-title":[],"issued":{"date-parts":[[2011,8,3]]},"references-count":28,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["1488"],"URL":"https:\/\/doi.org\/10.1007\/s00292-011-1488-1","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,3]]}}}